CDK4/6 Inhibitors in the Treatment of Metastatic Breast Cancer.

MLA

Ettl, Johannes, et al. “CDK4/6 Inhibitors in the Treatment of Metastatic Breast Cancer.” Breast Care (Basel, Switzerland), vol. 12, no. 2, May 2017, pp. 118–20. EBSCOhost, https://doi.org/10.1159/000475541.

APA

Ettl, J., Huober, J., Lüftner, D., Marmé, F., & Würstlein, R. (2017). CDK4/6 Inhibitors in the Treatment of Metastatic Breast Cancer. Breast Care (Basel, Switzerland), 12(2), 118–120. https://doi.org/10.1159/000475541

Chicago

Ettl, Johannes, Jens Huober, Diana Lüftner, Frederik Marmé, and Rachel Würstlein. 2017. “CDK4/6 Inhibitors in the Treatment of Metastatic Breast Cancer.” Breast Care (Basel, Switzerland) 12 (2): 118–20. doi:10.1159/000475541.